| 标题 |
Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Huiping Li; Jie-Qiong Liu; Quchang Ouyang; Shusen Wang; Ya-Xin Liu; et al 出版日期:2025-11-25 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)